Market Overview:
The global enalaprilat market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and other cardiovascular diseases, rising demand for generic drugs, and growing awareness about the benefits of enalaprilat. By type, the global enalaprilat market is segmented into 1mL vials and 2mL vials. The 1mL vial segment is expected to account for a larger share of the market than the 2mL vial segment during the forecast period. By application, hospital pharmacies are expected to account for a larger share of the global enalaprilat market than retail pharmacies duringthe forecast period.
Product Definition:
Enalaprilat is a drug used to treat high blood pressure and heart failure. It belongs to a class of drugs called ACE inhibitors.
1mL Vial:
1mL Vial is used for the storage of medications and contains about 0.09 mg of active ingredient. It is a type of pharmaceutical vial that is used to store various types of injectable drugs, including anticoagulants, anti-epileptics, antibiotics (erythromycin), antivirals (acyclovir), anesthetics & sedatives among others.
2mL Vial:
2mL Vial is used for the packaging of Enalaprilat. It is a clear, sterile solution containing the active pharmaceutical ingredient (API), which is used to treat hypertension and heart failure. The 2 mL vials are available with either a plastic or glass container and come in different colors that help differentiate them from other products in the market.
The 2 mL vials are widely accepted by hospitals, clinics,.
Application Insights:
The application segment includes hospital and pharmacy. Enalaprilat is most commonly used in the treatment of heart failure, hypertension, and renal impairment. In 2017, the heart failure segment dominated the global market owing to a high prevalence of this condition coupled with growing awareness about effective management of cardiovascular diseases among population across the globe.
In terms of revenue, the hospital application segment accounted for USD 142.3 million in 2017 due to increasing usage as an anti-clotting agent during surgeries and emergency treatment procedures related to blood disorders such as pulmonary embolism (PE) & deep vein thrombosis (DVT).
Regional Analysis:
North America was the largest regional market in 2017 owing to high demand for blood pressure lowering medicines. The region will retain its dominant position throughout the forecast years on account of rising incidence of hypertension coupled with increasing awareness about available drugs. In addition, presence of a large number of manufacturers in this region will help sustain the price level over coming years.
Asia Pacific is expected to be one of fastest growing regions during the forecast period due to factors such as improving healthcare infrastructure and economic development in emerging countries like China and India. Moreover, these countries are also majorly known for their low cost production which makes them an attractive place for pharmaceutical companies looking to set up manufacturing facilities at affordable costs. This is likely to have a positive impact on overall APE market growth over next few years.
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases
- Growing awareness about the benefits of Enalaprilat therapy
- Rising demand for better and more effective treatment options for hypertension and heart diseases
- Technological advancements in the field of cardiac care that are increasing the adoption of Enalaprilat therapy 5. Availability of generic versions of Enalaprilat that are making it more affordable for patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Enalaprilat Market Research Report
By Type
1mL Vial, 2mL Vial
By Application
Hospital, Pharmacy
By Companies
Hikma Pharmaceuticals, Teva(Barr Pharmaceuticals), Novartis(Hexal AG), SteriMax, KRKA, Cadila Pharmaceuticals, Balkan Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Enalaprilat Market Report Segments:
The global Enalaprilat market is segmented on the basis of:
Types
1mL Vial, 2mL Vial
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hikma Pharmaceuticals
- Teva(Barr Pharmaceuticals)
- Novartis(Hexal AG)
- SteriMax
- KRKA
- Cadila Pharmaceuticals
- Balkan Pharmaceuticals
Highlights of The Enalaprilat Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mL Vial
- 2mL Vial
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enalaprilat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enalaprilat is a medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins.
Some of the major companies in the enalaprilat market are Hikma Pharmaceuticals, Teva(Barr Pharmaceuticals), Novartis(Hexal AG), SteriMax, KRKA, Cadila Pharmaceuticals, Balkan Pharmaceuticals.
The enalaprilat market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enalaprilat Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Enalaprilat Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Enalaprilat Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Enalaprilat Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Enalaprilat Market Size & Forecast, 2018-2028 4.5.1 Enalaprilat Market Size and Y-o-Y Growth 4.5.2 Enalaprilat Market Absolute $ Opportunity
Chapter 5 Global Enalaprilat Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Enalaprilat Market Size Forecast by Type
5.2.1 1mL Vial
5.2.2 2mL Vial
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Enalaprilat Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Enalaprilat Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enalaprilat Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enalaprilat Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Enalaprilat Analysis and Forecast
9.1 Introduction
9.2 North America Enalaprilat Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Enalaprilat Market Size Forecast by Type
9.6.1 1mL Vial
9.6.2 2mL Vial
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Enalaprilat Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Enalaprilat Analysis and Forecast
10.1 Introduction
10.2 Europe Enalaprilat Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Enalaprilat Market Size Forecast by Type
10.6.1 1mL Vial
10.6.2 2mL Vial
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Enalaprilat Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Enalaprilat Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Enalaprilat Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Enalaprilat Market Size Forecast by Type
11.6.1 1mL Vial
11.6.2 2mL Vial
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Enalaprilat Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Enalaprilat Analysis and Forecast
12.1 Introduction
12.2 Latin America Enalaprilat Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Enalaprilat Market Size Forecast by Type
12.6.1 1mL Vial
12.6.2 2mL Vial
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Enalaprilat Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Enalaprilat Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Type
13.6.1 1mL Vial
13.6.2 2mL Vial
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enalaprilat Market: Competitive Dashboard
14.2 Global Enalaprilat Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hikma Pharmaceuticals
14.3.2 Teva(Barr Pharmaceuticals)
14.3.3 Novartis(Hexal AG)
14.3.4 SteriMax
14.3.5 KRKA
14.3.6 Cadila Pharmaceuticals
14.3.7 Balkan Pharmaceuticals